Nasreen Adam Vohra

Nasreen Adam Vohra

Auto-generated profile, based on publicly available information

Nasreen Adam Vohra

East Carolina University

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SPShari Pilon-Thomas
Shari Pilon-Thomas
AMAmy Mackay
Amy Mackay
NVNasreen Vohra
Nasreen Vohra
JMJames J. Mulé
James J. Mulé
Inhibition of antitumor T cell responses can be mediated by the productive interaction between the programmed death-1 (PD-1) receptor on T cells and its ligand PD-L1. PD-L1 is highly expressed on both murine bone marrow-derived dendritic cells (DCs) and B16 melanoma. In this study, in vitro blockade of PD-L1 interaction on DCs led to enhanced IFN-γ production and cytotoxicity by Ag-specific T cells. In vivo, the systemic administration of anti–PD-L1 Ab plus melanoma peptide-pulsed DCs resulted in a higher number of melanoma peptide-specific CD8+ T cells, but this combination was insufficient to delay the growth of established B16 melanoma. Although the addition of 600 rad of total body irradiation delayed tumor growth, further adoptive transfer of Ag-specific CD8+ T cells was needed to achieve tumor regression and long-term survival of the treated mice. Lymphopenic mice treated with anti–PD-L1 Ab demonstrated increased activation and persistence of adoptively transferred T cells, including a higher number of CD8+ T cells infiltrating the tumor mass. Together, these studies support the blocking of PD-L1 signaling as a means to enhance combined immunotherapy approaches against melanoma.

1 September 2016 in Journal of Surgical Research
Verified
Journal Article
Closed access
CMCatalina Mosquera
Catalina Mosquera
NKNicholas J. Koutlas
Nicholas J. Koutlas
KEKimberly C. Edwards
Kimberly C. Edwards
ASAshley Strickland
Ashley Strickland
NVNasreen A. Vohra
Nasreen A. Vohra
TFTimothy L. Fitzgerald
Timothy L. Fitzgerald

1 August 2015 in Surgery
Verified
Journal Article
Closed access
TFTimothy L. Fitzgerald
Timothy L. Fitzgerald
SDSamuel O. Dennis
Samuel O. Dennis
SKSwapnil D. Kachare
Swapnil D. Kachare
NVNasreen A. Vohra
Nasreen A. Vohra
EZEmmanuel E. Zervos
Emmanuel E. Zervos

31 December 2013 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
SKSwapnil D. Kachare
Swapnil D. Kachare
JWJan H. Wong
Jan H. Wong
NVNasreen A. Vohra
Nasreen A. Vohra
EZEmmanuel E. Zervos
Emmanuel E. Zervos
TFTimothy L. Fitzgerald
Timothy L. Fitzgerald

19 April 2013 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
TGTomar Ghansah
Tomar Ghansah
NVNasreen Vohra
Nasreen Vohra
KKKathleen Kinney
Kathleen Kinney
AWAmy Weber
Amy Weber
KKKrithika Kodumudi
Krithika Kodumudi
SPShari Pilon-Thomas
Shari Pilon-Thomas

23 August 2014 in Langenbeck's Archives of Surgery
Verified
Journal Article
Closed access
PDF file
TFTimothy L. Fitzgerald
Timothy L. Fitzgerald
JBJason Brinkley
Jason Brinkley
SBShannon Banks
Shannon Banks
NVNasreen Vohra
Nasreen Vohra
ZEZachary P. Englert
Zachary P. Englert
EZEmmanuel E. Zervos
Emmanuel E. Zervos